Compare KYMR & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYMR | SPXC |
|---|---|---|
| Founded | 2015 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.1B |
| IPO Year | 2020 | 1994 |
| Metric | KYMR | SPXC |
|---|---|---|
| Price | $104.20 | $215.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 26 | 9 |
| Target Price | $107.72 | ★ $245.56 |
| AVG Volume (30 Days) | 558.9K | ★ 593.7K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | N/A | ★ 2.73 |
| Revenue | $39,211,000.00 | ★ $2,265,100,000.00 |
| Revenue This Year | $10.61 | $16.07 |
| Revenue Next Year | $8.17 | $7.68 |
| P/E Ratio | ★ N/A | $78.44 |
| Revenue Growth | N/A | ★ 14.17 |
| 52 Week Low | $36.88 | $179.62 |
| 52 Week High | $130.05 | $251.08 |
| Indicator | KYMR | SPXC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.